nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Irinotecan—colon cancer	0.088	0.402	CbGbCtD
Sucralfate—ALB—Fluorouracil—colon cancer	0.0845	0.386	CbGbCtD
Sucralfate—ALB—Methotrexate—colon cancer	0.0466	0.213	CbGbCtD
Sucralfate—FGG—gall bladder—colon cancer	0.0293	0.0891	CbGeAlD
Sucralfate—FGB—gall bladder—colon cancer	0.0226	0.0688	CbGeAlD
Sucralfate—FGA—gall bladder—colon cancer	0.0194	0.0589	CbGeAlD
Sucralfate—EGF—endothelium—colon cancer	0.0163	0.0496	CbGeAlD
Sucralfate—PGA5—renal system—colon cancer	0.016	0.0486	CbGeAlD
Sucralfate—EGF—blood vessel—colon cancer	0.015	0.0457	CbGeAlD
Sucralfate—FGB—embryo—colon cancer	0.0143	0.0436	CbGeAlD
Sucralfate—PGA5—digestive system—colon cancer	0.0131	0.0398	CbGeAlD
Sucralfate—FGA—embryo—colon cancer	0.0123	0.0373	CbGeAlD
Sucralfate—FGB—renal system—colon cancer	0.0109	0.033	CbGeAlD
Sucralfate—FGA—renal system—colon cancer	0.00929	0.0283	CbGeAlD
Sucralfate—FGB—lymphoid tissue—colon cancer	0.00901	0.0274	CbGeAlD
Sucralfate—EGF—embryo—colon cancer	0.00896	0.0273	CbGeAlD
Sucralfate—FGB—digestive system—colon cancer	0.0089	0.0271	CbGeAlD
Sucralfate—FGG—liver—colon cancer	0.00859	0.0261	CbGeAlD
Sucralfate—FGB—bone marrow—colon cancer	0.00821	0.025	CbGeAlD
Sucralfate—FGA—lymphoid tissue—colon cancer	0.00771	0.0235	CbGeAlD
Sucralfate—FGA—digestive system—colon cancer	0.00762	0.0232	CbGeAlD
Sucralfate—EGF—epithelium—colon cancer	0.00731	0.0223	CbGeAlD
Sucralfate—EGF—smooth muscle tissue—colon cancer	0.00705	0.0214	CbGeAlD
Sucralfate—FGA—bone marrow—colon cancer	0.00702	0.0214	CbGeAlD
Sucralfate—EGF—renal system—colon cancer	0.00678	0.0206	CbGeAlD
Sucralfate—FGB—liver—colon cancer	0.00663	0.0202	CbGeAlD
Sucralfate—FGG—lymph node—colon cancer	0.00659	0.02	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—colon cancer	0.00622	0.0189	CbGeAlD
Sucralfate—FGA—liver—colon cancer	0.00568	0.0173	CbGeAlD
Sucralfate—EGF—lymphoid tissue—colon cancer	0.00563	0.0171	CbGeAlD
Sucralfate—EGF—digestive system—colon cancer	0.00556	0.0169	CbGeAlD
Sucralfate—EGF—vagina—colon cancer	0.00491	0.0149	CbGeAlD
Sucralfate—ALB—gall bladder—colon cancer	0.00489	0.0149	CbGeAlD
Sucralfate—FGF2—vagina—colon cancer	0.00434	0.0132	CbGeAlD
Sucralfate—EGF—liver—colon cancer	0.00415	0.0126	CbGeAlD
Sucralfate—EGF—lymph node—colon cancer	0.00318	0.00967	CbGeAlD
Sucralfate—FGF2—lymph node—colon cancer	0.0028	0.00853	CbGeAlD
Sucralfate—ALB—liver—colon cancer	0.00143	0.00436	CbGeAlD
Sucralfate—ALB—lymph node—colon cancer	0.0011	0.00334	CbGeAlD
Sucralfate—EGF—Innate Immune System—SRC—colon cancer	0.000123	0.000273	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000123	0.000271	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TGFB1—colon cancer	0.000123	0.000271	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—colon cancer	0.000122	0.00027	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APC—colon cancer	0.000121	0.000268	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APC—colon cancer	0.000121	0.000268	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—colon cancer	0.00012	0.000265	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—colon cancer	0.000119	0.000263	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NRAS—colon cancer	0.000119	0.000263	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—SRC—colon cancer	0.000119	0.000262	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000118	0.000261	CbGpPWpGaD
Sucralfate—EGF—Disease—FGFR3—colon cancer	0.000118	0.00026	CbGpPWpGaD
Sucralfate—FGA—Disease—CTNNB1—colon cancer	0.000118	0.00026	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000118	0.00026	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BRAF—colon cancer	0.000116	0.000257	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—colon cancer	0.000116	0.000256	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN1A—colon cancer	0.000115	0.000254	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NRAS—colon cancer	0.000114	0.000252	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BRAF—colon cancer	0.000114	0.000252	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BRAF—colon cancer	0.000114	0.000252	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—KRAS—colon cancer	0.000113	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—KRAS—colon cancer	0.000113	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDH1—colon cancer	0.000112	0.000249	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.000111	0.000245	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ODC1—colon cancer	0.00011	0.000242	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CHST5—colon cancer	0.00011	0.000242	CbGpPWpGaD
Sucralfate—FGA—Disease—EP300—colon cancer	0.000109	0.000242	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—colon cancer	0.000108	0.000239	CbGpPWpGaD
Sucralfate—EGF—Disease—APC—colon cancer	0.000108	0.000239	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDH1—colon cancer	0.000108	0.000238	CbGpPWpGaD
Sucralfate—FGA—Disease—SRC—colon cancer	0.000106	0.000235	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PIK3CA—colon cancer	0.000104	0.000231	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PIK3CA—colon cancer	0.000104	0.00023	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—colon cancer	0.000104	0.00023	CbGpPWpGaD
Sucralfate—FGA—Disease—NRAS—colon cancer	0.000102	0.000226	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—KRAS—colon cancer	0.000102	0.000226	CbGpPWpGaD
Sucralfate—EGF—Disease—BRAF—colon cancer	0.000102	0.000225	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—colon cancer	0.000101	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD8A—colon cancer	9.86e-05	0.000218	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—KRAS—colon cancer	9.81e-05	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CTNNB1—colon cancer	9.78e-05	0.000216	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—colon cancer	9.65e-05	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—colon cancer	9.64e-05	0.000213	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—colon cancer	9.53e-05	0.000211	CbGpPWpGaD
Sucralfate—FGA—Disease—TGFB1—colon cancer	9.51e-05	0.00021	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PIK3CA—colon cancer	9.39e-05	0.000208	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—colon cancer	9.32e-05	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EP300—colon cancer	9.09e-05	0.000201	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PIK3CA—colon cancer	9.01e-05	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—SRC—colon cancer	8.84e-05	0.000196	CbGpPWpGaD
Sucralfate—FGA—Disease—KRAS—colon cancer	8.8e-05	0.000195	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CASP3—colon cancer	8.72e-05	0.000193	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—colon cancer	8.69e-05	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CTNNB1—colon cancer	8.64e-05	0.000191	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—colon cancer	8.61e-05	0.00019	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CASP3—colon cancer	8.55e-05	0.000189	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CASP3—colon cancer	8.55e-05	0.000189	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—colon cancer	8.52e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—colon cancer	8.51e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NRAS—colon cancer	8.51e-05	0.000188	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—colon cancer	8.49e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDKN1A—colon cancer	8.44e-05	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2L1—colon cancer	8.44e-05	0.000187	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CTNNB1—colon cancer	8.41e-05	0.000186	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—colon cancer	8.34e-05	0.000184	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—colon cancer	8.32e-05	0.000184	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—colon cancer	8.32e-05	0.000184	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGFR3—colon cancer	8.24e-05	0.000182	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CTNNB1—colon cancer	8.24e-05	0.000182	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CTNNB1—colon cancer	8.24e-05	0.000182	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN1A—colon cancer	8.21e-05	0.000182	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—colon cancer	8.21e-05	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDKN1A—colon cancer	8.11e-05	0.000179	CbGpPWpGaD
Sucralfate—FGA—Disease—PIK3CA—colon cancer	8.09e-05	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGFR3—colon cancer	8.07e-05	0.000178	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN1A—colon cancer	8.05e-05	0.000178	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN1A—colon cancer	8.05e-05	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EP300—colon cancer	8.03e-05	0.000178	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTNNB1—colon cancer	7.95e-05	0.000176	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—colon cancer	7.91e-05	0.000175	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EP300—colon cancer	7.82e-05	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—SRC—colon cancer	7.81e-05	0.000173	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDKN1A—colon cancer	7.77e-05	0.000172	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—colon cancer	7.75e-05	0.000171	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—colon cancer	7.67e-05	0.00017	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EP300—colon cancer	7.66e-05	0.000169	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EP300—colon cancer	7.66e-05	0.000169	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SRC—colon cancer	7.6e-05	0.000168	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APC—colon cancer	7.57e-05	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NRAS—colon cancer	7.51e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—SRC—colon cancer	7.5e-05	0.000166	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—colon cancer	7.48e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR3—colon cancer	7.45e-05	0.000165	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SRC—colon cancer	7.45e-05	0.000165	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SRC—colon cancer	7.45e-05	0.000165	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—colon cancer	7.4e-05	0.000164	CbGpPWpGaD
Sucralfate—EGF—Immune System—EP300—colon cancer	7.39e-05	0.000163	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—colon cancer	7.36e-05	0.000163	CbGpPWpGaD
Sucralfate—EGF—Disease—CTNNB1—colon cancer	7.34e-05	0.000162	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—KRAS—colon cancer	7.32e-05	0.000162	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NRAS—colon cancer	7.31e-05	0.000162	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—colon cancer	7.25e-05	0.00016	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—colon cancer	7.25e-05	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NRAS—colon cancer	7.21e-05	0.00016	CbGpPWpGaD
Sucralfate—EGF—Immune System—SRC—colon cancer	7.19e-05	0.000159	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN1A—colon cancer	7.17e-05	0.000159	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NRAS—colon cancer	7.16e-05	0.000158	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NRAS—colon cancer	7.16e-05	0.000158	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BRAF—colon cancer	7.11e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Immune System—NRAS—colon cancer	6.91e-05	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—colon cancer	6.85e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Disease—APC—colon cancer	6.84e-05	0.000151	CbGpPWpGaD
Sucralfate—EGF—Disease—EP300—colon cancer	6.82e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDH1—colon cancer	6.82e-05	0.000151	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—colon cancer	6.81e-05	0.000151	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—colon cancer	6.79e-05	0.00015	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—colon cancer	6.67e-05	0.000148	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—colon cancer	6.67e-05	0.000148	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—colon cancer	6.66e-05	0.000147	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—colon cancer	6.66e-05	0.000147	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—colon cancer	6.66e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Disease—SRC—colon cancer	6.64e-05	0.000147	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—colon cancer	6.61e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—colon cancer	6.57e-05	0.000145	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—colon cancer	6.53e-05	0.000144	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—colon cancer	6.53e-05	0.000144	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—KRAS—colon cancer	6.47e-05	0.000143	CbGpPWpGaD
Sucralfate—FGF2—Disease—BRAF—colon cancer	6.43e-05	0.000142	CbGpPWpGaD
Sucralfate—EGF—Disease—NRAS—colon cancer	6.38e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—colon cancer	6.3e-05	0.000139	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KRAS—colon cancer	6.29e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—colon cancer	6.22e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KRAS—colon cancer	6.21e-05	0.000137	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	6.19e-05	0.000137	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KRAS—colon cancer	6.17e-05	0.000136	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KRAS—colon cancer	6.17e-05	0.000136	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	6.14e-05	0.000136	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	5.98e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Immune System—KRAS—colon cancer	5.95e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—colon cancer	5.95e-05	0.000132	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PIK3CA—colon cancer	5.94e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—colon cancer	5.93e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—colon cancer	5.82e-05	0.000129	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PIK3CA—colon cancer	5.78e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PIK3CA—colon cancer	5.71e-05	0.000126	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PIK3CA—colon cancer	5.66e-05	0.000125	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PIK3CA—colon cancer	5.66e-05	0.000125	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—colon cancer	5.59e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—colon cancer	5.5e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—colon cancer	5.5e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Disease—KRAS—colon cancer	5.49e-05	0.000122	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	5.49e-05	0.000121	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—colon cancer	5.48e-05	0.000121	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—colon cancer	5.48e-05	0.000121	CbGpPWpGaD
Sucralfate—EGF—Immune System—PIK3CA—colon cancer	5.47e-05	0.000121	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—colon cancer	5.35e-05	0.000118	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—colon cancer	5.33e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—colon cancer	5.28e-05	0.000117	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—colon cancer	5.24e-05	0.000116	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—colon cancer	5.24e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGFR3—colon cancer	5.22e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—colon cancer	5.19e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—colon cancer	5.19e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CTNNB1—colon cancer	5.14e-05	0.000114	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—colon cancer	5.06e-05	0.000112	CbGpPWpGaD
Sucralfate—EGF—Disease—PIK3CA—colon cancer	5.05e-05	0.000112	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTNNB1—colon cancer	5.03e-05	0.000111	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN1A—colon cancer	5.02e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDKN1A—colon cancer	4.92e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—colon cancer	4.85e-05	0.000107	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APC—colon cancer	4.79e-05	0.000106	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EP300—colon cancer	4.78e-05	0.000106	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—colon cancer	4.72e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EP300—colon cancer	4.68e-05	0.000103	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—colon cancer	4.67e-05	0.000103	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	4.67e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—colon cancer	4.66e-05	0.000103	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SRC—colon cancer	4.65e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Disease—CTNNB1—colon cancer	4.65e-05	0.000103	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—colon cancer	4.63e-05	0.000102	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—colon cancer	4.63e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SRC—colon cancer	4.55e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN1A—colon cancer	4.54e-05	0.0001	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.53e-05	0.0001	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—colon cancer	4.53e-05	0.0001	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BRAF—colon cancer	4.5e-05	9.96e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRAS—colon cancer	4.47e-05	9.89e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—colon cancer	4.47e-05	9.88e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRAS—colon cancer	4.38e-05	9.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EP300—colon cancer	4.32e-05	9.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SRC—colon cancer	4.2e-05	9.29e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—colon cancer	4.16e-05	9.21e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—colon cancer	4.15e-05	9.19e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—colon cancer	4.12e-05	9.12e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—colon cancer	4.07e-05	9.01e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRAS—colon cancer	4.04e-05	8.94e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—colon cancer	3.99e-05	8.82e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KRAS—colon cancer	3.85e-05	8.51e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.81e-05	8.43e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KRAS—colon cancer	3.77e-05	8.33e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—colon cancer	3.76e-05	8.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—colon cancer	3.75e-05	8.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—colon cancer	3.68e-05	8.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.56e-05	7.87e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3CA—colon cancer	3.54e-05	7.82e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—KRAS—colon cancer	3.48e-05	7.69e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3CA—colon cancer	3.46e-05	7.65e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—colon cancer	3.42e-05	7.56e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—colon cancer	3.38e-05	7.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—colon cancer	3.29e-05	7.27e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—colon cancer	3.27e-05	7.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CTNNB1—colon cancer	3.25e-05	7.2e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—EP300—colon cancer	3.25e-05	7.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—colon cancer	3.2e-05	7.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3CA—colon cancer	3.19e-05	7.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN1A—colon cancer	3.18e-05	7.03e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SRC—colon cancer	3.16e-05	7e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—colon cancer	3.08e-05	6.81e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NRAS—colon cancer	3.04e-05	6.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EP300—colon cancer	3.02e-05	6.69e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.96e-05	6.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—colon cancer	2.96e-05	6.54e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SRC—colon cancer	2.94e-05	6.5e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—colon cancer	2.9e-05	6.41e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—colon cancer	2.89e-05	6.39e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—colon cancer	2.86e-05	6.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TYMS—colon cancer	2.85e-05	6.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRAS—colon cancer	2.83e-05	6.26e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—colon cancer	2.83e-05	6.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—colon cancer	2.83e-05	6.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—colon cancer	2.64e-05	5.83e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—colon cancer	2.63e-05	5.81e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—KRAS—colon cancer	2.62e-05	5.79e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—colon cancer	2.61e-05	5.77e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—colon cancer	2.58e-05	5.7e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KRAS—colon cancer	2.44e-05	5.39e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3CA—colon cancer	2.41e-05	5.32e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—colon cancer	2.33e-05	5.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3CA—colon cancer	2.24e-05	4.95e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—colon cancer	2.23e-05	4.92e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.19e-05	4.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—colon cancer	2.16e-05	4.79e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—colon cancer	2.07e-05	4.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARG—colon cancer	2.02e-05	4.46e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—colon cancer	1.97e-05	4.35e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—colon cancer	1.83e-05	4.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—colon cancer	1.59e-05	3.51e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—EP300—colon cancer	1.32e-05	2.92e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3CA—colon cancer	9.76e-06	2.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—colon cancer	7.97e-06	1.76e-05	CbGpPWpGaD
